Jeff E. Knight
Chief Dev & Operating Officer · ALX ONCOLOGY HOLDINGS INC
- 2024
- Apr 17, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeff E. Knight files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Corey S. Goodman - $5.00M in ALXO purchases and sales in the last 12 months
- Richard Scott Struthers - $822K in CRNX purchases and sales in the last 12 months
- Dana Pizzuti - $438K in CRNX purchases and sales in the last 12 months
- Stephen F. Betz - $397K in CRNX purchases and sales in the last 12 months
- Stephanie Okey - $365K in CRNX purchases and sales in the last 12 months
- Coelho Rogerio Vivaldi - $301K in CRNX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeff E. Knight?
Jeff E. Knight is a corporate insider, tracked as Chief Dev & Operating Officer of ALX ONCOLOGY HOLDINGS INC (ALXO). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jeff E. Knight last file a Form 4?
The most recent primary Form 4 on record is dated 17 April 2026, one of 5 filings going back to 2024.
Has Jeff E. Knight been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($3.81M) across all tracked filings.
